Developing mRNA medicines to restore protein function.

We are a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.

Learn More

Translate Bio

We are pioneering the translation of mRNA therapeutics into transformative medicines.

Watch the Video

Recent News

11.12 2020
Translate Bio to Participate in Upcoming Investor Conferences
11.05 2020
Translate Bio Announces Third Quarter 2020 Financial Results and Reviews Recent Progress
10.15 2020
Sanofi and Translate Bio mRNA COVID-19 Vaccine Candidate Induced High Antibody Levels in Preclinical Studies
10.07 2020
Translate Bio Highlights mRNA Platform Potential for the Treatment of Cystic Fibrosis (CF) at the 34th Annual North American Cystic Fibrosis Conference

View All

@TranslateBio